WhiteOak Capital Pharma and Healthcare Fund-Reg (G) - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Status: Open
Portfolio Overview
As of February 28, 2026
Asset Allocation
Equity: 98.70%Others: 1.30%
Market Cap
Large Cap: 17.37%Small Cap: 42.65%Mid Cap: 28.54%Others: 10.14%
Number of stocks
58
Top 10 Holdings
117.11% of portfolio
Market Cap of Equity
Large Cap
17.3699%
Small Cap
42.6482%
Mid Cap
28.5363%
Others
10.1424%
Companies Allocation of Equity
Sun Pharmaceuticals Industries Ltd23.69%
J.B. Chemicals & Pharmaceuticals Ltd18.89%
Max Healthcare Institute Ltd Ordinary Shares11.75%
Fortis Healthcare Ltd11.08%
Lupin Ltd10.57%
Apollo Hospitals Enterprise Ltd10.16%
Divi's Laboratories Ltd9.48%
Laurus Labs Ltd8.65%
Krishna Institute of Medical Sciences Ltd7.90%
Sai Life Sciences Ltd4.93%
Sector Allocation of Equity
Healthcare86.77%
Basic Materials7.10%
Equity4.83%
SIP Amount
Monthly SIP Date
WhiteOak Capital Pharma and Healthcare Fund-Reg (G)


Is This Mutual Fund Right for You?
+10k investors used our Suitability Test to get better returns
Fund Suitability Test
Let's Get Started.
Frequently Asked Questions
Everything You Need To Know To Get Started With Confidence
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.